Johnson Pharmacare Complete Financial Statements
JOHNPHARMA • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Johnson Pharmacare (JOHNPHARMA).
Downloads include all available records across all periods.
For market performance, see the
JOHNPHARMA stock price today
.
Profitability Ratios
Return on Assets
-1.72%
2025 data
Return on Equity
-1.79%
2025 data
Balance Sheet Ratios
Current Ratio
1.00
2025 data
Debt to Equity
1.04
2025 data
Equity Ratio
96.55%
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Expense Growth
-100.0%
Year-over-Year
Assets Growth
-3.3%
Year-over-Year
Equity Growth
-1.8%
Year-over-Year
Liabilities Growth
-3.3%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 3 | 3 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 1 | 0 | 4 | 3 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| EBITDA | -1 | -1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit Margin % | 0.00% | 0.00% | 0.00% | -53.00% | 4.00% | 0.00% | 0.00% | -1.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -1 | -1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -1 | -1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings Per Share (₹) | 0.00 | -0.01 | 0.00 | -0.02 | 0.00 | 0.00 | -0.02 | 0.00 | -0.01 | -0.02 | -0.03 | -0.01 |
Related Pages for Johnson Pharmacare
Additional stock information and data for JOHNPHARMA
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 58 | 60 | 60 | 60 | 60 | 59 | 60 | 60 | 59 | 59 | 60 |
| Current Assets | 1 | 0 | 0 | 1 | 6 | 5 | 5 | 4 | 4 | 22 | 4 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 42 | 46 | 46 | 54 | 52 | 52 | 53 | 54 | 54 | 8 | 0 |
| Other Assets | 16 | 14 | 14 | 6 | 7 | 7 | 7 | 6 | 5 | 51 | 60 |
| LIABILITIES | |||||||||||
| Total Liabilities | 58 | 60 | 60 | 60 | 60 | 59 | 60 | 60 | 59 | 59 | 60 |
| Current Liabilities | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 56 | 57 | 57 | 58 | 58 | 58 | 58 | 58 | 58 | 58 | 59 |
| Share Capital | 55 | 55 | 55 | 55 | 50 | 50 | 50 | 50 | 50 | 50 | 50 |
| Reserves & Surplus | 1 | 2 | 2 | 3 | 8 | 8 | 8 | 8 | 8 | 8 | 9 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -2 | 0 | 0 | 5 | 0 | 0 | -1 | -1 | 11 | -11 | 8 |
| Investing Activities | 3 | 0 | -1 | -5 | 0 | 1 | 1 | 0 | -11 | 11 | 10 |
| Financing Activities | -1 | 0 | 1 | 0 | 0 | -1 | 0 | 1 | 0 | 0 | 2 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21 |